Literature DB >> 6699436

Influence of bacterial-antibiotic interactions on subsequent antimicrobial activity of alveolar macrophages.

W L Hand, N L King-Thompson, J D Johnson.   

Abstract

The efficacy of an antibiotic in the treatment of bacterial infections depends upon the interactions of drug, bacteria, and phagocytes. In an examination of certain of these interactions, overnight cultures of 3H-labeled Staphylococcus aureus were briefly incubated in the presence or absence of various antibiotics prior to phagocytosis by rabbit alveolar macrophages. Preincubation of organisms with an inhibitor of bacterial protein synthesis (clindamycin, erythromycin, chloramphenicol, or rifampin) but not with a cell wall-active drug (penicillin G or cefazolin) led to an increase in phagocytosis and early intracellular killing by alveolar macrophages. Antibiotic-mediated susceptibility of S aureus to ingestion by alveolar macrophages correlated with the inhibition of bacterial protein synthesis. Clindamycin-treated staphylococci were more efficiently opsonized by heat-inactivated serum and bound larger amounts of specific antibody than did control organisms. Thus, compromise of one or more antiphagocytic surface components secondary to decreased protein synthesis is the means by which certain antibiotics influence bacterial susceptibility to the antimicrobial mechanisms of phagocytes. This effect may be an important determinant in the success of treatment with inhibitors of bacterial protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699436     DOI: 10.1093/infdis/149.2.271

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Phagocyte uptake and transport of azithromycin.

Authors:  P J McDonald; H Pruul
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

3.  Effect of phagocyte membrane stimulation on antibiotic uptake and intracellular bactericidal activity.

Authors:  T H Steinberg; W L Hand
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

4.  Penetration of brodimoprim into human neutrophils and intracellular activity.

Authors:  P C Braga; M Dal Sasso; S Maci; G Bondiolotti; E Fonti; S Reggio
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 5.  Intracellular concentrations of antibacterial agents and related clinical implications.

Authors:  J D Butts
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

6.  An in vitro system to study listericidal capacity of macrophages from separate mice: resident macrophages exhibit different activation patterns.

Authors:  D Ottendorfer; D Bitter-Suermann; U Hadding
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.

Authors:  W L Hand; M L Butera; N L King-Thompson; D L Hand
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

8.  Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity.

Authors:  W L Hand; N L King-Thompson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

9.  Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.

Authors:  F Namavar; J A Kaan; A M Verweij-van Vught; W A Vel; M Bal; A D Kester; D M MacLaren
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

10.  Phagocytic function and antibody-dependent cellular cytotoxicity of human neutrophils in the presence of N-formimidoyl thienamycin.

Authors:  A B Rodriguez; C Barriga; M de la Fuente
Journal:  Agents Actions       Date:  1990-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.